|Bid||123.69 x 1000|
|Ask||124.10 x 1000|
|Day's Range||121.85 - 124.54|
|52 Week Range||58.72 - 144.49|
|Beta (5Y Monthly)||1.36|
|PE Ratio (TTM)||37.73|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
The worst result, after buying shares in a company (assuming no leverage), would be if you lose all the money you put...
Good morning, and thank you for joining Medpace's third-quarter 2020 earnings conference call. Also on the call today is: our president and CEO, August Troendle; and our CFO and COO of laboratory operations, Jesse Geiger.
Medpace (MEDP) delivered earnings and revenue surprises of 4.63% and 2.74%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?